Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and...
Demand for a new shot that protects babies against respiratory syncytial virus has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants.
Babies ages 8 to 19 months old should not receive Beyfortus because they are eligible for an older medication known as palivizumab , CNN reported. Unlike Beyfortus, which protects babies for 6 months with a single dose, Synagis has to be given once a month through the RSV season.RSV can infect the lower lungs, causing them to fill with mucus, which can make it hard for infants to breathe and eat. RSV is the leading cause of hospitalization in infants younger than 1 year old.
“While deliveries of 100-mg doses continue, new orders are not being taken by Sanofi at this time,” the company told CNN.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC issues alert over high RSV vaccine demandRSV is a cold-like nuisance for most people, and not as well-known as the flu but packs hospitals every winter.
Read more »
CDC updates RSV shot recommendations due to drug shortagesThe agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
Read more »
As RSV cases tick up, CDC warns that a key drug to keep babies safe is in short supplyBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
State tracking COVID, flu, and RSV cases in new online dashboardThe Alabama Department of Public Health has launched a new dashboard for tracking respiratory viruses.
Read more »
A seasonal viral stew is brewing with flu, RSV, COVID and moreNational data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.
Read more »
Mike Pence faces questions about how much longer his 2024 campaign can survive amid cash shortagePence ended September with just $1.18 million cash-on-hand, according to recent filings, and owed $621,000 in debt.
Read more »